QIAGEN’s Post

In this week’s interview with BiotechTV, our CEO Thierry BERNARD describes latest sample, assay, and bioinformatics technologies that are powering life sciences and molecular diagnostics. He discusses the scientific and clinical advances underlying our focus areas: sample technologies, QuantiFERON, QIAstat-Dx, and digital PCR (dPCR). Watch the full interview to learn how these innovations are powering the future of research and healthcare 👉 https://lnkd.in/gAKWgWuq

 🌟 Gastrointestinal (GI) panels are transforming care for patients with suspected GI infections. They’re reducing diagnosis times, cutting down on invasive tests and ensuring peace of mind. 🔍 Curious about how they can support your practice? ✅ Learn more about these advancements through clinical cases and publication summaries at 👉 https://lnkd.in/evfh8SWu #Healthcare #GIPanels #PatientCare #ClinicalCases

Up to 13 million people in the US carry latent TB infection – and children are at increased risk for progression from infection to contagious active TB disease. Children are also commonly exposed to settings with a higher risk for TB transmission, like schools and childcare centers. 

At QIAGEN, we believe that our commitment to diversity and inclusion drives our success and innovation. By creating an environment where everyone feels accepted and valued, we empower our team to reach their highest potential.    #pridemonth #LGBTQ #QIAversity #diversity #inclusion

🤔 Do you wish you had a smile as nice as a Neanderthal’s? Celebrate World Microbiome Day by discovering the surprisingly great teeth of these extinct people, and what they might teach us about the modern oral microbiome 👉 https://lnkd.in/eFi_5cth

🔍 Gastrointestinal (GI) infections can affect anyone. But certain groups are at higher risk for serious complications.   💡 Syndromic GI panel tests can help doctors diagnose these infections quickly and accurately. This can lead to better treatment outcomes. Which group of patients can benefit most from these tests?   ✅ Find out how GI panels are transforming patient care. 👉 https://lnkd.in/ehDgriJz

At QIAGEN, we are committed to fostering an inclusive environment where every individual feels valued and heard. Our strength lies in our diversity and the unique perspectives of our team members. Join us in celebrating Pride Month and the voices that make us stronger. #Pridemonth #LGBTQ #QIAversity #diversity #inclusion

🤔 Curious about our sustainability achievements in 2023? Download the full report here 👉 https://lnkd.in/efwEmzz2 We're excited to share our progress on ESG and our commitment to sustainable growth in 2023. Environment: In 2023, we achieved a 15% reduction in Scope 1 and 2 emissions and cut our plastic usage by 7%. Social: Over the past six years, we have increased women's representation in leadership roles from 28% to 36%. Our new target is to reach at least 40% by 2027. In 2023, we strengthened our collaborative efforts through partnerships with various organizations to make diagnostic solutions universally accessible. Governance: Our ethical supplier policy continues to make an impact. As of now, 80% of our suppliers, measured by spend, have committed to achieving at least one environmental and one social goal. Our journey toward sustainability is ongoing, and we do not intend to relent. Discover the full details in our report. 

On Monday, we rang the closing bell at the NYSE to mark our targets for 2028! Our leadership team presented the company’s mid-term goals to the financial community and our strategy until 2028. Learn more 👉 https://lnkd.in/eePvDwq4